Offer - Urjas Oil for just ₹ 1 X
Alfakim 250 Mg Injection is a commercial drug that is prescribed in the form of Injection. It is primarily used for the treatment of Urinary Tract Infection. Secondary and off-label uses of Alfakim 250 Mg Injection have also been mentioned below.
The correct dosage of Alfakim 250 Mg Injection depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
While these are the most often observed Alfakim 250 Mg Injection side effects, there are can be others also. These have been listed below. These side effects of Alfakim 250 Mg Injection are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Alfakim 250 Mg Injection's effect during pregnancy is Severe and Unknown while nursing. It is important to know if Alfakim 250 Mg Injection has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Alfakim 250 Mg Injection related warnings section.
Alfakim 250 Mg Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Alfakim 250 Mg Injection in conditions like Dehydration, Parkinson's Disease, Hearing Loss. Some other conditions that can be affected by Alfakim 250 Mg Injection are listed in the contraindications section below.
Besides this, Alfakim 250 Mg Injection may also have severe interaction with some medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Alfakim 250 Mg Injection is considered safe while driving, and is addictive.
Alfakim 250 Mg Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Alfakim 250 Mg Injection safe for pregnant women?
Alfakim should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Alfakim 250 Mg Injection safe during breastfeeding?
In the absence of any scientific study about the side effects of Alfakim in breastfeeding women, information on safety of Alfakim is unavailable.
What is the effect of Alfakim 250 Mg Injection on the Kidneys?
Consumption of Alfakim can harm the kidneys. So it is important to take medical advice beforehand.
What is the effect of Alfakim 250 Mg Injection on the Liver?
Very few cases of side effects of Alfakim on the liver have been reported.
What is the effect of Alfakim 250 Mg Injection on the Heart?
Very few cases of side effects of Alfakim on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Alfakim 250 Mg Injection unless your doctor advises you to do so -
Is this Alfakim 250 Mg Injection habit forming or addictive?
No, you will not get addicted to Alfakim 250 Mg Injection.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Alfakim 250 Mg Injection since it will not make you feel sleepy.
Is it safe?
Yes, Alfakim 250 Mg Injection is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Alfakim 250 Mg Injection is not used to treat mental disorders.
Interaction between Food and Alfakim 250 Mg Injection
Taking Alfakim 250 Mg Injection with food is safe.
Interaction between Alcohol and Alfakim 250 Mg Injection
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Alfakim 250 Mg Injection.
Occasionally, Alfakim can cause drug-induced thrombocytopenia (blood clot formation in the vessel). However, if you experience severe thrombocytopenia after taking this medicine, please immediately seek medical help.
Alfakim can be safely taken as prescribed by your doctor. Do not discontinue the medicine suddenly or take it longer than prescribed duration.
Alfakim is a broad-spectrum antibiotic which is active against both Gram-positive and Gram-negative bacteria. It works by preventing the synthesis of proteins that bacteria need to survive, in the absence of protein synthesis bacteria become vulnerable and dies. It is effective against different types of bacteria such as Escherichia coli, Proteus species, S. aureus, Acinetobacter and Serratia species.
Yes, Alfakim has been reported to cause ototoxicity (hearing loss or deafness) which is irreversible and may progress after discontinuation of the drug. It is a common side effect of this medicine. If you experience hearing loss or deafness after consuming or applying for this medicine, then consult your doctor and follow his/her instructions.
Alfakim is a brand name for amikacin. It is a prescription drug which belongs to the class of medication known as an aminoglycoside antibiotic. It is a broad spectrum antibiotic which is used for the treatment of bacterial infection such as bone, joint, skin, intra-abdominal, pneumonia, and respiratory tract infection. It is used for short-term treatment (7 - 10 days) of bacterial infection in different part of the body. It is also used for the treatment of neonatal sepsis when sensitivity testing indicates that other aminoglycosides cannot be used.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Arikayce (amikacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-137